Gene therapy products, namely, pharmaceutical preparation vectors for use in gene therapy, clinical medical reagents, therapeutic compositions containing vectors for gene therapy for use in the treatment of cancer, neurological, ocular, hearing, balance and auto-immune disorders; Enzymes and enzyme preparations for gene therapy purposes, retro viral vector and retro viral vector manufacturing preparations, all for the field of gene therapy, for the treatment of prostate cancer, with the exclu...

Gene therapy products, namely, pharmaceutical preparation vectors for use in gene therapy, clinical medical reagents, therapeutic compositions containing vectors for gene therapy for use in the treatment of cancer, neurological, ocular, hearing, balance and auto-immune disorders; enzymes and enzyme preparations for gene therapy purposes, retroviral vector and retroviral vector manufacturing preparations, all for the field of gene therapy, for the treatment of prostate cancer

Clinical medical reagents for use in gene therapy; pharmaceutical preparations, namely, vaccines for use in gene therapy; therapeutic compositions containing liposome reagents or nucleic acid suitable for gene therapy for use in the treatment of cancer and auto-immune disorders; pharmaceutical preparations containing nucleic acids for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS-related infections and bodily conditions associated with impaired immunosystems, si...

clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations of the treatment of prostate cancer; pharmaceutical preparations containing nucleic acid for use in the treatment of prostate cancer